Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more ...
While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.
Atherosclerotic Cardiovascular Disease (ASCVD), including conditions such as heart attacks and strokes, remains a leading ...
This Phase 1 grant (1R43HL174270) is funded by the National Heart, Lung, and Blood Institute (NHLBI) for the further ...
In a paper published in MedComm, a Chinese team of researchers present the prognostic role of Lipoprotein(a) [Lp(a)] in ...
Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...
A trailblazing review proposed that poor oral health particularly periodontal disease can cause atherosclerotic ...
Leerink Partners analyst Thomas Smith has reiterated their bullish stance on TRML stock, giving a Buy rating yesterday. Thomas Smith’s ...
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death among U.S. adults. Despite declining rates of ASCVD mortality, significant disparities across multiple social and ...
THE Philippine Press Institute (PPI) has spearheaded a health reporting workshop to help local journalists gain a deeper ...
Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Tourmaline Bio (TRML – Research Report). The associated ...
BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk prediction. We sought to investigate the use of a plasma proteomics-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback